About
Marc Ettensohn, MD graduated from the University of Louisville School of Medicine and completed his psychiatry residency program at the University of Florida School of Medicine, where he served as Chief Resident for the University of Florida Department of Psychiatry. He also completed an ECT fellowship at Emory University and an administrative fellowship at the American Board of Psychiatry and Neurology. After his training, he became the medical director for the private practice, Actify of South Florida, specializing in the use of intravenous and intranasal ketamine for treatment-resistant anxiety and depressive disorders. Afterwards, he went on to develop his own private practice, Cornerstone Psychiatric Care, which continues to focus on interventional treatment for psychiatric disorders and frequently utilizes ketamine therapy. Part-time, he provides hospital consultation and psychiatric inpatient care. As a diplomate of the American Board of Psychiatry and Neurology, he serves as an ambassador and committee member for The Board. He is also an active member of the American Psychiatric Association, The Florida Psychiatric Society, and the American Society of Ketamine Physicians. He has coauthored several peer-reviewed papers in the medical literature, describing the use of ketamine for psychiatric disorders, such as Advances in Psychedelic Medicine: State-of-the-Art Therapeutic Applications* and The Rise of Ketamine in Clinical practice^.
Jaison Nainaparampil, MD graduated from the University of Cincinnati College of Medicine and completed his residency training in general psychiatry at the University of Florida (UF). After finishing residency, Dr. Nainaparampil continued training at UF to complete his fellowship in child and adolescent psychiatry. He joined Cornerstone Psychiatric Care in February 2021 to continue his passion of helping those who suffer from mental illness. He is a diplomate of the American Board of Psychiatry and Neurology and is certified in both General Psychiatry and Child & Adolescent Psychiatry. He is also an active member of the American Psychiatric Association, The American Academy of Child and Adolescent Psychiatry, and The Florida Psychiatric Society. Dr. Nainaparampil is a staunch advocate of mental health awareness; he facilitated (and performed in) the theatrical production: Inside OCD: I am not my illness. The performance premiered at the Squitieri Studio Theatre in Gainesville, FL and was presented at the 2018 International OCD Foundation Conference in Washington, D.C. and the 2019 American Psychiatric Association Annual Meeting in San Francisco, CA. Dr. Nainaparampil believes in holistic and compassionate care, and he frequently utilizes psychotherapy as well as psychotropic medication to ensure the best outcomes for his patients.
Diane Esposito, PhD, APRN, PMHCNS-BC graduated from Bloomsburg University with a BSN in Nursing in 1987, an MSN in Psychiatric Mental Health Nursing from Adelphi University in 1996, and PhD in Nursing from Barry University in 2013. Shas worked as a Psychiatric Nurse Practitioner in the State of Florida since 1998 and is ANCC Board Certified as a Clinical Nurse Specialist in Child and Adolescent Mental Health.
Dr. Esposito has served as Education Council Chair of the American Psychiatric Nurses Association (APNA), a professional nursing association of over 13,000 members, in 2018 received the Florida Psychiatric Nurse of the Year and in 2019 the Excellence in Education award. Dr. Esposito has served on the Board of Directors for the APNA FL Chapter, as well as for the National Alliance on Mental Illness (NAMI) of Palm Beach. Dr. Esposito has presented on a national level on Trauma and Recovery, Mental Health Needs for Athletes as well as topics related to Addiction. Dr. Esposito incorporates a holistic approach in caring for her clients’ mind body and spirit, has completed training in Christian counseling and has served in spiritual healing ministry. Dr. Esposito currently serves as full time faculty in the Doctor of Nursing Practice Program at Palm Beach Atlantic University.
Dr. Esposito has served as Education Council Chair of the American Psychiatric Nurses Association (APNA), a professional nursing association of over 13,000 members, in 2018 received the Florida Psychiatric Nurse of the Year and in 2019 the Excellence in Education award. Dr. Esposito has served on the Board of Directors for the APNA FL Chapter, as well as for the National Alliance on Mental Illness (NAMI) of Palm Beach. Dr. Esposito has presented on a national level on Trauma and Recovery, Mental Health Needs for Athletes as well as topics related to Addiction. Dr. Esposito incorporates a holistic approach in caring for her clients’ mind body and spirit, has completed training in Christian counseling and has served in spiritual healing ministry. Dr. Esposito currently serves as full time faculty in the Doctor of Nursing Practice Program at Palm Beach Atlantic University.
Jessica Shepley, MSN, APRN, FNP-BC, CRNI is a certified registered infusion nurse and a board-certified Family Nurse Practitioner. She began her career as a registered nurse in 2006 taking care of patients in the Pediatric Intensive Care and Cardiovascular Intensive Care Units and then specializing in infusion therapy for patients with rare chronic illnesses. Since 2016, Jessica has been working in psychiatry alongside Dr. Ettensohn, providing ketamine infusions for patients with many psychiatric conditions, including treatment-resistant depression. She has been responsible for training nurses in accessing the bloodstream through veins, intravenous ketamine administration, and monitoring blood properties. In addition to her extensive clinical experience, Jessica also completed her Master of Science in Nursing from Chamberlain University in a graduate program focusing on patients across the lifespan. Combining her knowledge from the intensive care unit, infusion care, psychiatry, and family medicine, she has developed the ability to treat her patients not only medically but holistically. Jessica believes that establishing a connection between the nurse and patient is imperative for providing unsurpassed care. She is an active member of several professional organizations, including the Infusion Nurses Society, American Psychiatric Nurses Association, American Nurses Association, and Sigma Theta Tau, the Honor Society of Nursing.
Set Up Phone Consultation via Text or Call
|
Address:
8895 N. Military Trail Suite 300-E Palm Beach Gardens, FL 33410 Text or Call: (561) 531-7818 Fax: (844) 912-1511 Email: info@cp.care |
*McInnes A, Ettensohn MF. 2019. Chap. 5: Ketamine Therapy for Treatment-Resistant Depression. In Winkelman MJ, Sessa B (Eds.), Advances in Psychedelic Medicine: State-of-the-Art Therapeutic Applications (pp. 81-101). Santa Barbara, CA: ABC-CLIO, LLC.
^Dugar A, Ettensohn MF, Levine SP. 2018. Ketamine and Its Pharmacologic Profile in Psychiatric Disorders. Psychiatr Ann. 48(4):170-174 https://doi.org/10.3928/00485713-20180314-01
^Klise A, Lerner B, Ettensohn MF, Levine SP. 2018. Ketamine Treatment for Mood Disorders. Psychiatr Ann. 48(4):175-179 https://doi.org/10.3928/00485713-20180315-01
^Ettensohn MF, Markey S, Levine SP. 2018. Considering Ketamine Treatment for Comorbid Pain, Depressive and Substance Use Disorders. Psychiatr Ann. 48(4):180-183 https://doi.org/10.3928/00485713-20180312-02
^Dougherty JW III, Ettensohn MF, Levine SP. 2018. Beyond Depression: Ketamine and glutamatergic agents for PTSD, OCD, and other potential applications. Psychiatr Ann. 48(4):184-188 https://doi.org/10.3928/00485713- 20180312-03.
Dr. Ettensohn has no financial interest in sales of the above texts.
^Klise A, Lerner B, Ettensohn MF, Levine SP. 2018. Ketamine Treatment for Mood Disorders. Psychiatr Ann. 48(4):175-179 https://doi.org/10.3928/00485713-20180315-01
^Ettensohn MF, Markey S, Levine SP. 2018. Considering Ketamine Treatment for Comorbid Pain, Depressive and Substance Use Disorders. Psychiatr Ann. 48(4):180-183 https://doi.org/10.3928/00485713-20180312-02
^Dougherty JW III, Ettensohn MF, Levine SP. 2018. Beyond Depression: Ketamine and glutamatergic agents for PTSD, OCD, and other potential applications. Psychiatr Ann. 48(4):184-188 https://doi.org/10.3928/00485713- 20180312-03.
Dr. Ettensohn has no financial interest in sales of the above texts.